U.S. Tobacco Stock News

NasdaqGS:RRR
NasdaqGS:RRRHospitality

Is It Time To Reconsider Red Rock Resorts (RRR) After Recent Share Price Weakness

Wondering if Red Rock Resorts at around US$58.74 is offering good value right now, or if most of the upside is already priced in. The stock is roughly flat over the last week with a 0.4% decline, softer over the past month with an 8.2% decline and year to date is down 6.7%. Over the past year it has returned 38.9% and over five years 125.5%. Recent coverage has focused on how Red Rock Resorts fits into broader casino and local gaming trends, with attention on how its Las Vegas centric...
NYSE:TT
NYSE:TTBuilding

Trane Technologies’ DOE Progress Tests Valuation As Field Trials Begin

Trane Technologies (NYSE:TT) progressed in the U.S. Department of Energy Commercial Building HVAC Technology Challenge, completing all required laboratory testing. The company received special recognition for exceeding optional cold climate performance targets for rooftop units. Trane Technologies advanced to real world field trials while also reporting continued strong results in the DOE Residential Cold Climate Heat Pump Challenge. Trane Technologies, known for its commercial and...
NYSE:POR
NYSE:PORElectric Utilities

Portland General Electric Expands Debt Capacity For PacifiCorp Asset Acquisition

Portland General Electric (NYSE:POR) has entered into two unsecured credit agreements that together provide access to more than $1b in new debt financing. The company plans to use the funds for capital projects and to acquire PacifiCorp’s electric transmission, distribution, and generation assets in Washington. These agreements introduce new funding structures, covenants, and timelines tied directly to this planned asset purchase. Portland General Electric, trading at $51.49, is pursuing a...
NYSE:ICL
NYSE:ICLChemicals

ICL Group NYSE ICL Valuation Check After New India Fertilizer Facility Announcement

ICL Group (ICL) is back in focus after announcing a new specialty fertilizer facility in Maharashtra, India, aimed at supporting local production as geopolitical tensions disrupt key global shipping routes. See our latest analysis for ICL Group. Despite the India expansion headlines, ICL's recent share price moves have been subdued, with a 7 day share price return of a 4.28% decline and a year to date share price return of an 11.05% decline, while the 5 year total shareholder return sits at...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

ADP Study Highlights Job Insecurity And Implications For HR Outsourcing Demand

ADP Research released a new global workforce study highlighting widespread job insecurity among employees worldwide. Only 22% of workers surveyed said they are strongly confident their jobs are secure, despite low unemployment levels. The report flags higher concern among lower paid, repetitive roles and lower management positions. Automatic Data Processing (NasdaqGS:ADP), trading at around $204.89, is coming off a challenging stretch, with the share price down 19.0% year to date and 29.8%...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Ondas (ONDS) Quarterly Loss Narrows To US$8.8 Million Challenging Bearish Profitability Narratives

Ondas FY 2025 results set the stage for a tighter focus on profitability Ondas (ONDS) just posted its FY 2025 numbers with third quarter revenue at about US$10.1 million and a basic EPS loss of US$0.03, alongside trailing twelve month revenue of roughly US$24.7 million and a cumulative net loss of about US$47.7 million. Over recent quarters, the company has seen revenue move from around US$0.96 million in Q2 2024 to US$1.48 million in Q3 2024, then to US$4.25 million in Q1 2025, US$6.27...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

New Recursion CMO Puts Oncology Experience At Center Of Investor Focus

Recursion Pharmaceuticals (NasdaqGS:RXRX) has appointed Vicki Goodman, M.D., as Chief Medical Officer, effective April 6, 2026. Dr. Goodman succeeds David Mauro, M.D., Ph.D., and brings more than 20 years of oncology drug development leadership. Her background includes senior roles at Mural Oncology, Exelixis, Merck, Bristol Myers Squibb, and GlaxoSmithKline, with experience on major oncology products such as KEYTRUDA, OPDIVO, and YERVOY. For investors tracking Recursion Pharmaceuticals at...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

US High Growth Tech Stocks to Watch Now

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings expected to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability, positioning themselves well amidst fluctuating market conditions.
NasdaqGS:AAON
NasdaqGS:AAONBuilding

Top Growth Stocks With High Insider Ownership In March 2026

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating conditions and promising growth prospects, identifying stocks with high insider ownership can be advantageous as it often signals confidence from those closely tied to a company's success.
NYSE:BLND
NYSE:BLNDSoftware

Aldeyra Therapeutics And 2 More Promising Penny Stocks For Your Watchlist

Over the last 7 days, the U.S. market has dropped 2.3%, though it has risen by 13% over the past year, with earnings expected to grow by 16% per annum in the coming years. In light of these conditions, identifying stocks with strong fundamentals becomes crucial, particularly when exploring opportunities outside mainstream investments. Although "penny stocks" is a somewhat outdated term, it still refers to smaller or less-established companies that can offer significant potential; here we...
NasdaqCM:XPEL
NasdaqCM:XPELAuto Components

US Market's Top 3 Undiscovered Gems With Strong Potential

Over the last 7 days, the United States market has experienced a slight decline of 2.3%, although it has shown resilience with a 13% rise over the past year and an optimistic forecast of 16% annual earnings growth. In this dynamic environment, identifying stocks with strong potential often involves looking beyond well-known names to find those undiscovered gems that align with current growth trends and market conditions.
NasdaqGS:FITB
NasdaqGS:FITBBanks

3 Reliable Dividend Stocks Offering Up To 3.7% Yield

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In such a dynamic environment, selecting dividend stocks with reliable yields can provide stability and income potential for investors seeking to navigate market fluctuations.
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Is Safety Insurance Group (SAFT) Fairly Priced After Recent Share Price Softness?

Wondering whether Safety Insurance Group at around US$73.39 is a sensible entry or hold for you right now? This article focuses squarely on what the current price might imply about value. The stock has been fairly steady in the very short term with a 0.8% return over the last week. The past month shows a 6.4% decline and the year-to-date return sits at a 3.1% decline, alongside a 1.7% decline over the past year, a 14.6% return over three years and a 7.8% return over five years. Recent...
NYSE:HLIO
NYSE:HLIOMachinery

Is It Too Late To Consider Helios Technologies (HLIO) After Its 98% One Year Surge?

If you are wondering whether Helios Technologies at around US$67.54 is still attractively priced after a big run, the key question is what you are really paying for today. The stock has moved 4.0% over the last 7 days, sits on a year to date return of 23.5%, and has delivered 98.3% over the last year, although the past 30 days show a 9.0% decline that may have shifted perceptions of risk and opportunity. Recent coverage around Helios Technologies has focused on how its share price...
NYSE:CMP
NYSE:CMPMetals and Mining

Accelerated Debt Redemption Might Change The Case For Investing In Compass Minerals International (CMP)

In March 2026, Compass Minerals International, Inc. completed the full redemption of the US$150,000,000 aggregate principal amount of its 6.750% Senior Notes due 2027 using cash on hand, paying 100% of principal plus accrued interest to the redemption date. This move marks an acceleration of the company’s balance sheet transformation and debt reduction efforts, which may enhance financial flexibility and lower interest costs. We’ll now examine how this accelerated debt redemption shapes...
NYSE:KVYO
NYSE:KVYOSoftware

Klaviyo’s New AI Composer And Upgrades Tested Against Valuation Discount

Klaviyo (NYSE:KVYO) has launched Composer, an AI-driven agentic tool designed to build full marketing campaigns. The company also rolled out expanded Customer Agent capabilities and more than 75 new features across marketing, data, analytics, and customer service. These changes represent a broad update to Klaviyo's marketing automation platform, aimed at unifying workflows and customer data. Klaviyo operates in marketing automation and customer engagement, an area where brands are looking...
NasdaqGM:MDB
NasdaqGM:MDBIT

MongoDB Names New CRO To Sharpen AI And Cloud Revenue Execution

MongoDB (NasdaqGM:MDB) has appointed Ryan Mac Ban as Chief Revenue Officer. The new CRO is tasked with driving the next phase of growth in AI and cloud data markets. This leadership change follows other recent executive additions at the company. For investors watching MongoDB, the new CRO role sits at the center of how the company turns demand for AI and multi cloud data platforms into actual revenue. MongoDB focuses on modern database and developer data tools that are widely used in cloud...
NYSE:PB
NYSE:PBBanks

Is Prosperity Bancshares (PB) Price Weakness Creating A Potential Opportunity For Investors?

Wondering whether Prosperity Bancshares at around US$66 is offering good value today, or if the price already reflects its strengths? This article breaks down what the numbers are really saying about the stock. The share price is around US$66.41 after a recent 2.9% gain over the last 7 days, set against a 9.7% decline over 30 days and a 4.6% decline year to date and over 1 year, with a 3 year return of 18.6% and 5 year return of 2.8%. Recent coverage has focused on how Prosperity Bancshares...
NasdaqCM:OCGN
NasdaqCM:OCGNBiotechs

Is Ocugen (OCGN) Pricing Make Sense After Its Volatile Multi‑Year Share Price Swings

If you are wondering whether Ocugen's current share price still makes sense after a strong run, the key question is how that price lines up with the underlying value of the business. Ocugen shares, which last closed at US$1.92, have had a mixed but attention grabbing run, with a 21.6% decline over the last 7 days, a 20.0% gain over 30 days, 39.1% year to date, 168.6% over 1 year and 131.3% over 3 years, set against a 71.6% loss over 5 years. Recent news coverage has focused on Ocugen's...
NasdaqGS:HSAI
NasdaqGS:HSAIAuto Components

Hesai Group (NasdaqGS:HSAI) Profitability Turn Reinforces Bullish Earnings Growth Narratives

Hesai Group (NasdaqGS:HSAI) has just posted its FY 2025 third quarter numbers, with revenue of C¥795.4 million and basic EPS of C¥1.88 setting the tone for the latest update. The company has seen quarterly revenue move from C¥458.9 million in Q2 2024 to C¥719.8 million in Q4 2024 and then to C¥795.4 million in Q3 2025. Basic EPS has shifted from a loss of C¥0.56 per share in Q2 2024 to C¥1.13 in Q4 2024 and C¥1.88 in Q3 2025, pointing to a business where margins are increasingly in focus for...